理财产品投资

Search documents
联诚精密出售资产 上半年仍亏损
Zhong Guo Jing Ying Bao· 2025-10-09 07:45
山东联诚精密制造股份有限公司(以下简称"联诚精密",002921.SZ)近期发布《关于出售资产的公 告》(以下简称"《出售资产公告》")称,联诚精密根据战略发展规划,提高资产综合使用效率,以及 优化资产、增强资产流动性,公司拟将位于济宁市兖州区的一处工业用地及厂房、设备设施等以6213万 元(含税)的价格出售给上海康帅冷链科技股份有限公司(以下简称"康帅冷链"),康帅冷链与其不存 在关联关系。 从收入端主要产品来看,其乘用车零件收入1.09亿元,占营收比重的19.90%,同比增长89.77%,毛利率 为18.42%;农机/工程机械零件收入1.67亿元,占营收比重为30.44%,同比下滑24.50%,毛利率为 9.71%;商用车零件收入1.09亿元,占营收比重19.76%,同比下滑5.74%,毛利率为8.47%;压缩机零件 收入0.97亿元,占比17.73%,同比增长16.76%,毛利率为15.65%。 分地区来看,外销收入2.81亿元,占营收比重51.16%,同比下降6.90%;内销收入2.53亿元,占比 45.99%,同比增长14.71%。 上半年,联诚精密营业成本为4.79亿元,同比增长4.53%。其中乘 ...
昭衍新药(06127.HK):昭衍(苏州)新药认购工商银行合共4000万元理财产品
Sou Hu Cai Jing· 2025-09-19 10:40
昭衍新药(06127.HK)发布公告,于2025年9月19日(交易时间后),集团成员公司昭衍(苏州)新药刚与工商 银行订立协议,认购两项工商银行理财产品合共人民币4000万元,且连同公告日期仍未赎回的该等工商 银行理财产品合计投资总额为人民币4.1亿元。 截至2025年9月19日收盘,昭衍新药(06127.HK)报收于23.38港元,下跌2.83%,成交量600.81万股,成交 额1.4亿港元。投行对该股的评级以强烈推荐为主,近90天内共有2家投行给出强烈推荐评级。招商证券 最新一份研报给予昭衍新药强烈推荐评级。 机构评级详情见下表: | 股票代码 股票简称 投行名称 发布日期 评级 目标价 (港元) | | --- | | 06127.HK 昭衍新药 招商证券 2025-08-28 强烈推荐 | | 06127.HK 昭衍新药 招商证券 2025-07-21 强烈推荐 | 昭衍新药港股市值28.63亿港元,在医疗服务Ⅱ行业中排名第14。主要指标见下表: | 指标 | 昭衍新药 | 医疗服务 行业平均 | 行业排名 | | --- | --- | --- | --- | | ROE | 3.74% | 0.0 ...
比音勒芬: 关于使用闲置自有资金进行现金管理的进展公告
Zheng Quan Zhi Xing· 2025-09-04 11:14
《中国证券报》 《上海证券报》 证券代码:002832 证券简称:比音勒芬 公告编号:2025- 030 比音勒芬服饰股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 比音勒芬服饰股份有限公司(以下简称"公司")于 2024 年 9 月 29 日召开 第五届董事会第五次会议、第五届监事会第四次会议,会议审议通过了《关于增 加使用闲置自有资金进行现金管理额度的议案》,同意公司及子公司在不影响正 常生产经营和确保资金安全的情况下,使用不超过人民币 24 亿元的闲置自有资 金进行现金管理。此次审议的现金管理额度期限自董事会通过之日起 12 个月内 有效,在上述额度及有效期内,资金可滚动使用。具体内容详见 2024 年 9 月 30 日公司指定信息披露媒体《证券时报》 四、尚未到期理财产品的情况 截至本公告日,公司使用闲置自有资金购买理财产品尚未到期的本金金额为 五、备查文件 特此公告。 比音勒芬服饰股份有限公司董事会 《证券日报》 和巨潮资讯网(www.cninfo.com.cn)的相关公告。 根据上述决议,公司就近日购买理财产品的相关事宜公告如下: 一 ...
每周股票复盘:XD陕鼓动(601369)陕鼓动力召开股东大会审议多项议案
Sou Hu Cai Jing· 2025-07-12 22:32
Core Viewpoint - The company, Xi'an Shaangu Power Co., Ltd., is undergoing significant governance changes, including the cancellation of its supervisory board and the introduction of new financial management strategies, which may impact its operational structure and financial performance [1][3][4]. Group 1: Company Announcements - The company announced the convening of its second extraordinary general meeting on July 25, 2025, to discuss several key proposals, including amendments to the company’s articles of association and the cancellation of the supervisory board [1][3]. - The company plans to purchase principal-protected financial products with a maximum daily balance limit of RMB 5.7 billion, sourced from its own funds, with a maximum investment period of 365 days [2][3]. - The company has decided to cancel the bank loan guarantee of EUR 68.376 million for Shaangu Power (Hong Kong) Co., Ltd. [2][3]. Group 2: Governance Changes - The company has proposed to amend its articles of association and eliminate the supervisory board, transferring its responsibilities to the audit committee of the board of directors [3][4]. - The company has nominated Ren Kun as a candidate for a non-independent director on the ninth board of directors, with the term starting from the date of approval at the general meeting [2][3]. - The company will repurchase and cancel 2,124,541 shares of restricted stock, resulting in a reduction of registered capital from RMB 1,725,599,033 to RMB 1,723,474,492 [2].
齐峰新材: 关于使用自有资金进行现金管理的进展公告
Zheng Quan Zhi Xing· 2025-07-07 09:17
Core Viewpoint - Qifeng New Materials Co., Ltd. has approved the use of idle self-owned funds for cash management, allowing for the purchase of low-risk, high-liquidity financial products up to 1.2 billion RMB [1]. Cash Management Overview - The company has agreed to use up to 1.2 billion RMB of its idle self-owned funds for cash management, which can be rolled over [1]. - The cash management involves investing in low-risk financial products, specifically non-principal guaranteed floating income products [1]. Investment Details - The total amount of entrusted financial products signed is 255 million RMB [2]. - The expected annualized return rates for various products include: - Agricultural Bank's "Nongyin Shishi" open-ended product: 1.80% [2]. - Bank of China’s "Zhongyin Lixiang" product: 2.00% [2]. - Industrial and Commercial Bank's "ICBC Yiren" product: 2.30% [2]. - The investment periods for these products range from 2024 to 2025 [2]. Risk Analysis - The financial products purchased are primarily low-risk but are still subject to macroeconomic policy changes and potential operational errors [2]. - The company has established internal controls and audit measures to monitor the use and safety of the invested funds [2]. Impact on Daily Operations - The funds used for investment are idle and do not affect the company's daily cash flow or main business operations [2]. - The financial health of the company remains stable, and the investment is expected to enhance the returns on idle funds [2]. Historical Cash Management Activities - Over the past twelve months, the company has engaged in cash management activities involving various financial products, with expected returns ranging from 1.45% to 2.60% [2][3]. - The total amount of self-owned funds utilized for cash management in the past year is detailed in the financial product tables [2][3].
科伦博泰生物-B(06990)认购一系列理财产品
智通财经网· 2025-05-08 13:49
Group 1 - Company announced the sale of a large transferable certificate of deposit from Industrial Bank to Tongwei for a consideration of 52.8325 million RMB on March 21, 2025 [1] - On May 8, 2025, the company purchased a large transferable certificate of deposit from Industrial Bank for 53.0363 million RMB [1] - The total unpaid principal amount of financial products held by the company at Industrial Bank is 250 million RMB, which includes a 70 million RMB large transferable certificate of deposit and a 130 million RMB structured deposit [1] Group 2 - On May 8, 2025, the company entered into a structured deposit agreement with Zheshang Bank, agreeing to subscribe to two structured deposits, each with a principal amount of 200 million RMB [1] - The total unpaid principal amount of financial products held by the company at Zheshang Bank is 550 million RMB, including two structured deposits of 75 million RMB each and the two new structured deposits of 200 million RMB each [1] Group 3 - On May 8, 2025, the company entered into a structured deposit agreement with China Merchants Bank, agreeing to subscribe to a structured deposit with a principal amount of 100 million RMB [2] - The total unpaid principal amount of financial products held by the company at China Merchants Bank is 300 million RMB, which includes a 200 million RMB structured deposit and the new 100 million RMB structured deposit [2] Group 4 - On May 8, 2025, the company entered into a structured deposit agreement with CITIC Bank, agreeing to subscribe to a structured deposit with a principal amount of 250 million RMB [2] - The total unpaid principal amount of financial products held by the company at CITIC Bank is 400 million RMB, which includes a 150 million RMB large transferable certificate of deposit and the new 250 million RMB structured deposit [2]